ClinicalTrials.Veeva

Menu

Labor Analgesia With Ropivacaine and Clonidine (LA)

U

UPECLIN HC FM Botucatu Unesp

Status

Completed

Conditions

Labor Pain

Treatments

Drug: ropivacaine and clonidine
Drug: ropivacaine

Study type

Observational

Funder types

Other

Identifiers

NCT00626977
upeclin/HC/FMB-Unesp-07

Details and patient eligibility

About

The aim of the present study was to examine, for pain relief during labor, the efficacy of two pharmacological approaches - the 0.125% ropivacaine alone and the 0.0625% ropivacaine added to 75 ug clonidine, both by epidural administration. The effect of the drugs on mother and newborn was also determined.

Enrollment

32 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Singleton healthy
  • Full-term pregnancy
  • American Society of Anesthesiologists physical status I or II

Exclusion criteria

  • Patients who had received opioids
  • History of hypersensitivity to local anesthetic or to clonidine
  • Fetus showed signs of possible intrauterine suffering
  • Fetus showed signs of possible neurological deficit

Trial design

32 participants in 2 patient groups

R
Description:
R group:15 mL of 0.125% ropivacaine (18.75 mg)
Treatment:
Drug: ropivacaine
RC
Description:
RC group:0.0625% ropivacaine (9.375 mg) plus 75 ug clonidine
Treatment:
Drug: ropivacaine and clonidine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems